Although this may be different in other neurodegenerative diseases that, unlike MS, are not characterized by a severely-compromised blood-brain barrier, and are not primarily mediated by peripheral immune cells, IL-13 and IL-4 also showed protection in a mouse model of Alzheimer’s disease (AD). This evidence concerns the gene IL13 and myeloid sarcoma.